Zydus Lifesciences Ltd

BSE Code : 532321
NSE Symbol : ZYDUSLIFE
ISIN : INE010B01027
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

974.95 -7.80(-0.79%)

Open Price (₹)

986.95

Prev. Close (₹)

982.75

Volume (No’s)

726,018

Market Cap (₹)

98,102.78

Low Price (₹)

969.95

High Price (₹)

986.95 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Profit and Loss

	Mar 2025 (₹.Cr)	Mar 2024 (₹.Cr)	Mar 2023 (₹.Cr)	Mar 2022 (₹.Cr)	Mar 2021 (₹.Cr)	Mar 2020 (₹.Cr)
INCOME :
Sales Turnover	15,116.30	10,818.70	8,731.60	7,836.90	7,780.00	6,347.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	15,116.30	10,818.70	8,731.60	7,836.90	7,780.00	6,347.40
Other Income	696.20	1,084.80	548.40	178.70	89.30	908.70
Stock Adjustments	121.10	131.70	-105.10	46.90	148.30	-15.50
Total Income	15,933.60	12,035.20	9,174.90	8,062.50	8,017.60	7,240.60
EXPENDITURE :
Raw Materials	3,138.00	3,284.60	3,066.20	2,917.10	2,499.70	1,936.20
Power & Fuel Cost	286.20	298.20	278.60	245.20	193.20	208.40
Employee Cost	1,762.20	1,507.50	1,321.90	1,204.90	1,147.30	1,077.40
Other Manufacturing Expenses	439.70	347.20	332.50	381.10	363.40	327.30
Selling & Administrative Expenses	1,384.00	1,017.80	1,039.80	958.40	1,009.10	925.30
Miscellaneous Expenses	491.00	445.00	336.90	578.30	594.40	486.20
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	7,501.10	6,900.30	6,375.90	6,285.00	5,807.10	4,960.80
Operating Profit	8,432.50	5,134.90	2,799.00	1,777.50	2,210.50	2,279.80
Interest	463.90	390.70	278.20	134.90	70.90	233.90
Gross Profit	7,968.60	4,744.20	2,520.80	1,642.60	2,139.60	2,045.90
Depreciation	523.90	504.40	488.60	478.70	451.10	428.90
Profit Before Tax	7,444.70	4,239.80	2,032.20	1,163.90	1,688.50	1,617.00
Tax	1,582.50	934.30	461.80	260.20	303.30	164.10
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	87.30	-136.00	41.20	45.80	-91.00	40.00
Reported Net Profit	5,774.90	3,441.50	1,529.20	857.90	1,476.20	1,412.90
Extraordinary Items	27.40	3.90	-92.27	-237.64	-156.95	-52.67
Adjusted Net Profit	5,747.50	3,437.60	1,621.47	1,095.54	1,633.15	1,465.57
Adjustment below Net Profit	-26.40	-54.00	1.80	-6.90	-15.30	-6.00
P & L Balance brought forward	13,347.60	10,567.40	9,289.40	8,796.90	7,336.00	6,645.70
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	301.90	607.30	253.00	358.50	0.00	716.60
P & L Balance carried down	18,794.20	13,347.60	10,567.40	9,289.40	8,796.90	7,336.00
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1,100.00	300.00	600.00	250.00	350.00	350.00
Dividend Per Share(Rs)	11.00	3.00	6.00	2.50	3.50	3.50
Earnings Per Share-Unit Curr	57.40	34.21	15.11	8.38	14.42	13.80
Earnings Per Share(Adj)-Unit Curr	57.40	34.21	15.11	8.38	14.42	13.80
Book Value-Unit Curr	210.64	156.23	134.78	129.30	124.46	109.96
Book Value(Adj)-Unit Curr	210.64	156.23	134.78	129.30	124.46	109.96